Forthcoming UK asthma guidelines: an opportunity to improve asthma outcomes

Lancet. 2021 Nov 20;398(10314):1856-1858. doi: 10.1016/S0140-6736(21)02244-3. Epub 2021 Oct 14.

Authors

Andy Bush¹, Ian D Pavord²

Affiliations

¹ Imperial Centre for Paediatrics and Child Health and Paediatric Respiratory Medicine, National Heart and Lung Institute, Imperial College, London, UK; Royal Brompton and Harefield NHS Foundation Trust, London SW3 6NP, UK. Electronic address: a.bush@rbht.nhs.uk.
² NIHR Respiratory Biomedical Research Centre and Respiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

PMID: 34656285
DOI: 10.1016/S0140-6736(21)02244-3

No abstract available

MeSH terms

Anti-Asthmatic Agents / administration & dosage
Asthma / diagnosis*
Asthma / drug therapy
Asthma / therapy*
Disease Management*
Humans
Practice Guidelines as Topic*
Treatment Adherence and Compliance
United Kingdom

Substances

Anti-Asthmatic Agents